Journal of Shandong University (Health Sciences) ›› 2023, Vol. 61 ›› Issue (12): 94-99.doi: 10.6040/j.issn.1671-7554.0.2023.0490

• Clinical Medicine • Previous Articles    

Efficacy and safety of neuroendoscopy and borehole drainage in the treatment of massive chronic subdural hematoma

QIAN Ming, JIANG Lei, WANG Xuejian, ZHAO Wei, WANG Zhifeng, ZHANG Yi   

  1. Department of Neurosurgery, Affiliated Hospital 2 of Nantong University, Nantong 226000, Jiangsu, China
  • Published:2024-01-11

Abstract: Objective To investigate the efficacy and safety of neuroendoscopy and borehole drainage in the treatment of chronic subdural hematoma(CSDH). Methods Clinical data of 117 CSDH patients hospitalized in our department during Jan. 2020 and Dec. 2022 were retrospectively analyzed. The patients were divided into two groups according to the surgical approaches, 52 cases in the neuroendoscopic group and 65 cases in the borehole drainage group. The demography, CT imaging, clinical efficacy, postoperative complications and recurrence rate were compared between the two groups. Results Compared with the borehole drainage group, the neuroendoscopic group had a shorter drainage tube retention time and hospital stay, and higher hematoma clearance rate(P<0.05), but longer operation time. There was no significant difference in the incidence of postoperative complications between the two groups. The neuroendoscopic group had a better prognosis at the 3-month follow-up. Conclusion Both neuroendoscopy and borehole drainage can effectively treat CSDH, while neuroendoscopy has a higher hematoma clearance rate, shorter retention of drainage tube and hospital stay, and better clinical efficacy.

Key words: Chronic subdural hematoma, Neuroendoscopy, Borehole drainage, Safety

CLC Number: 

  • R651
[1] Almenawer SA, Farrokhyar F, Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients [J]. AnnSurg, 2014, 259(3): 449-457.
[2] Matsumoto H, Hanayama H, Okada T, et al. Clinical investigation of chronic subdural hematoma with impending brain herniation on arrival [J]. Neurosurg Rev, 2018,41(2): 447-455.
[3] Zeng L, Yu J, Chen R, et al. Modified valsalva maneuver after burr-hole drainage of chronic subdural hematomas: a single-center cohort study [J]. Front Neurol, 2022, 13: 1069708. doi: 10.3389/fneur.2022.1069708.
[4] Zhang J, Chen J. The therapeutic effects of craniotomy versus endoscopic-assisted trepanation drainage for isolated chronic subdural haematoma(ICSH): a single-centre long-term retrospective comparison study [J]. Brain Res Bull, 2020, 161: 94-97. doi: 10.1016/j.brainresbull.2020.04.014.
[5] Chen J, Xu J, Malkasian D, et al. The mini-craniotomy for cSDH revisited: new perspectives [J]. Front Neurol, 2021, 12: 660885. doi: 10.3389/fneur.2021.660885.
[6] Saway B, Roth W, Salvador C, et al. Subdural evacuation port system and middle meningeal artery embolization for chronic subdural hematoma: a multicenter experience [J]. J Neurosurg, 2023, 139(1): 131-138.
[7] Desir L, Narayan V, Ellis J, et al. Middle meningeal artery embolization in the management of chronic subdural hematoma: a comprehensive review of current literature [J]. Curr Neurol Neurosci Rep, 2023, 23(4): 109-119.
[8] Salih M, Shutran M, Young M, et al. Reduced recurrence of chronic subdural hematomas treated with open surgery followed by middle meningeal artery embolization compared to open surgery alone: a propensity score-matched analysis [J]. J Neurosurg, 2023, 139(1): 124-130.
[9] Bartley A, Bartek J, Jakola A, et al. Effect of irrigation fluid temperature on recurrence in the evacuation of chronic subdural hematoma: a randomized clinical trial [J]. JAMA Neurology, 2023, 80(1): 58-63.
[10] Markwalder T. The course of chronic subdural hematomas after burr-hole craniostomy with and without closed-system drainage [J]. Neurosurg Clin N Am, 2000, 11(3): 541-546.
[11] Salih M, Young M, Garcia A, et al. Outcome of chronic subdural hematoma intervention in patients on long-term antiplatelet therapy-a propensity score matched analysis [J]. Neurosurgery, 2023, 93(3): 586-591.
[12] 江荣才,王硕,张建宁.药物将成为治疗慢性硬膜下血肿的新模式[J]. 中华医学杂志, 2020, 100(8): 561-562. JIANG Rongcai, WANG Shuo, ZHANG Jianning. New drug therapy for chronic subdural hematoma is changing the treatment mode of the disease [J]. National Medical Journal of China, 2020, 100(8): 561-562.
[13] Onyinzo C, Berlis A, Abel M, et al. Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone [J]. J Neurointerv Surg, 2022, 14(3): 297-300.
[14] Salih M, Young M, Shutran M, et al. Effect of long-term anticoagulant therapy on the outcome of chronic subdural hematoma: a propensity score-matched analysis [J]. J Neurosurg, 2023, 139(1): 194-200.
[15] Martinez-Gutierrez J, Zeineddine H, Nahhas M, et al. Middle meningeal artery embolization for chronic subdural hematomas with concurrent antithrombotics [J]. Neurosurgery, 2023, 92(2): 258-262.
[16] Singh H, Patir R, Vaishya S, et al. Endoscopic evacuation of septated chronic subdural hemorrhage - Technical considerations, results, and outcome [J]. Surg Neurol Int, 2022, 13: 8. doi: 10.25259/SNI_963_2021.
[17] Brennan PM, Kolias AG, Joannides AJ, et al. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom [J]. J Neurosurg, 2017, 124(3): 732-739.
[18] Tanaka T, Fujimoto S, Saito K, et al. Histological study of operated cases of chronic subdural hematoma in adults: relationship between dura mater and outer membrane [J]. No Shinkei Geka Neurological Surgery, 1997, 25(8): 701-705.
[19] Huang Y, Yang K, Lee T, et al. Bilateral chronic subdural hematoma: what is the clinical significance? [J]. Int J Surg, 2013, 11(7): 544-548.
[20] Lin M. Subdural lesions linking additional intracranial spaces and chronic subdural hematomas: a narrative review with mutual correlation and possible mechanisms behind high recurrence [J]. Diagnostics(Basel), 2023, 13(2): 235.
[21] Hong K, Hsu S, Chen C, et al. Endoscope-assisted manipulation of chronic subdural hematomas provides a novel solution for eliminating the septum and inner membrane leading to reduced recurrence [J]. In Vivo, 2022, 36(6): 2774-2779.
[22] Munoz-Bendix C, Pannewitz R, Remmel D, et al. Outcome following surgical treatment of chronic subdural hematoma in the oldest-old population [J]. Neurosurgical Review, 2017, 40(3): 461-468.
[23] Wu L, Guo X, Ou Y, et al. Efficacy analysis of neuroendoscopy-assisted burr-hole evacuation for chronic subdural hematoma: a systematic review and meta-analysis [J]. Neurosurg Rev, 2023, 46(1): 98.
[24] Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study [J]. J Neurosurg, 2004, 100(1): 24-32.
[25] Vychopen M, Güresir E, Wach J. Anti-inflammatory drug therapy in chronic subdural hematoma: a systematic review and meta-analysis of prospective randomized, double-blind and placebo-controlled trials [J]. Int J Mol Sci, 2022, 23(24): 16198. doi: 10.3390/ijms232416198.
[26] Guo S, Gao W, Cheng W, et al. Endoscope-assisted surgery vs. burr-hole craniostomy for the treatment of chronic subdural hematoma: a systemic review and meta-analysis [J]. Front Neurol, 2020, 11: 540911. doi: 10.3389/fneur.2020.540911.
[27] Hamou H, Alzaiyani M, Rossmann T, et al. Seizure after surgical treatment of chronic subdural hematoma-Associated factors and effect on outcome [J]. Front Neurol, 2022,13: 977329. doi: 10.3389/fneur.2022.977329.
[28] 孙涛,韩易,姜之全,等.改良护脑双腔引流管在慢性硬膜下血肿外引流术中的应用[J]. 中华医学杂志, 2018, 98(45): 3681-3685. SUN Tao, HAN Yi, JIANG Zhiquan, et al. Application of modified brain protection double-lumen drainage tube in external drainage of chronic subdural hematoma [J]. National Medical Journal of China, 2018, 98(45): 3681-3685.
[1] MA Xiang, ZHAO Feiyan. Status and progress of oocyte cryopreservation [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 19-23.
[2] Hongling WEN,Xiaoying XU. Prevention and control of emerging viral infectious diseases and biosafety [J]. Journal of Shandong University (Health Sciences), 2021, 59(5): 40-45.
[3] ZHANG Yingchun. Safety of human assisted reproductive technology offspring [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 52-59.
[4] HAO Guimin, LUO Zhuoye, CUI Na. Hazards of common complications in assisted reproductive technology [J]. Journal of Shandong University (Health Sciences), 2019, 57(10): 7-12.
[5] LÜ Huimin, ZHANG Mengwei, NIU Limin, ZENG Huiai, YAN Min. Efficacy and safety of single-agent domestic docetaxel in the treatment of advanced breast cancer [J]. Journal of Shandong University (Health Sciences), 2018, 56(1): 45-49.
[6] JIAO Fengping, ZHANG Haitao, ZHAO Yinghui, TIAN Zhaoju, YANG Shulin. Preliminary study of tissue distribution and safety of HSV-2 DNA vaccine in mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 38-42.
[7] LIU Songtao, SHEN Bin, LIN Hui, LI Xiangwei, WEN Zhaoke. A comparative study of total thoracoscopic mitral valve replacement under heart beating and heart arrest [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 39-43.
[8] XU Chuang, QI Dachun, LI Xianrang, ZU Meng, LI Jian, LIU Mingting. Do we really need wound drainage in hip arthroplasty? A meta-analysis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(6): 43-49.
[9] FENG Zichao, WANG Jiwei, LI Chao, LI Weiguo, CHEN Teng, MA Xiangyu, XU Shujun, LI Xingang. Role of pure neuroendoscopy in cerebellopontine angle area surgery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(10): 71-75.
[10] WANG Jiwei, LI Chao, CHEN Teng, ZHANG Wenhua, LI Weiguo, MA Xiangyu, XU Shujun, LI Xingang. Simple endoscopic vascular decompression in the treatment of trigeminal neuralgia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(4): 83-86.
[11] WANG Chunlai, XU Shujun, WANG Hongliang, SHANG Jingrui. Neuroendoscopic repair of traumatic cerebrospinal fluid rhinorrhea [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 69-72.
[12] HOU Xin-guo, ZHOU Ke-hua, ZHEN Xiao-hui, SONG Jun, ZHANG Liang, JIAO Lei, CHEN Li . Efficacy and safety of recombinant human glucagonlike peptide-1 in combination with metformin in patients with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 1-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!